132 related articles for article (PubMed ID: 1866552)
21. Effects of liposomal amphotericin B versus an amphotericin B lipid complex on liver histopathology in patients with hematologic malignancies and invasive fungal infections: a retrospective, nonrandomized autopsy study.
Chamilos G; Luna M; Lewis RE; Chemaly R; Raad II; Kontoyiannis DP
Clin Ther; 2007 Sep; 29(9):1980-6. PubMed ID: 18035197
[TBL] [Abstract][Full Text] [Related]
22. The current role of amphotericin B lipid complex in managing systemic fungal infections.
Chu P; Sadullah S
Curr Med Res Opin; 2009 Dec; 25(12):3011-20. PubMed ID: 19849324
[TBL] [Abstract][Full Text] [Related]
23. Do not abandon amphotericin B as an antifungal bladder irrigant.
Wise GJ
Clin Infect Dis; 2005 Oct; 41(7):1073-4; author reply 1074. PubMed ID: 16142684
[No Abstract] [Full Text] [Related]
24. [A study on urinary fungal infection].
Takeuchi H; Arai Y; Konami T; Ikeda T; Tomoyoshi T; Tatewaki K
Hinyokika Kiyo; 1983 Oct; 29(10):1273-7. PubMed ID: 6100418
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of amphotericin B encapsulated in liposomes (AmBisome) in the treatment of invasive fungal infections in immunocompromised patients.
Ringdén O; Meunier F; Tollemar J; Ricci P; Tura S; Kuse E; Viviani MA; Gorin NC; Klastersky J; Fenaux P
J Antimicrob Chemother; 1991 Oct; 28 Suppl B():73-82. PubMed ID: 1778894
[TBL] [Abstract][Full Text] [Related]
26. [Importance of mycoses in intra-abdominal infections].
Blinzler L; Fischer K; Just HM; Heuser D
Langenbecks Arch Chir; 1997; 382(4 Suppl 1):S5-8. PubMed ID: 9333708
[TBL] [Abstract][Full Text] [Related]
27. Lipid formulations of amphotericin B.
Dix SP; Andriole VT
Curr Clin Top Infect Dis; 2000; 20():1-23. PubMed ID: 10943516
[TBL] [Abstract][Full Text] [Related]
28. [Epidemiology and therapy of mycotic infections in immunocompromised host with special regard to the role of lipid formulations of amphotericin B].
Viscoli C; Castagnola E
Recenti Prog Med; 1999 Oct; 90(10):545-57. PubMed ID: 10592741
[TBL] [Abstract][Full Text] [Related]
29. Liposomal amphotericin B (AmBisome) in the treatment of fungal infections in neutropenic patients.
Chopra R; Blair S; Strang J; Cervi P; Patterson KG; Goldstone AH
J Antimicrob Chemother; 1991 Oct; 28 Suppl B():93-104. PubMed ID: 1778896
[TBL] [Abstract][Full Text] [Related]
30. Genitourinary fungal infections.
Michigan S
J Urol; 1976 Oct; 116(4):390-7. PubMed ID: 802858
[TBL] [Abstract][Full Text] [Related]
31. A brief review of antifungal therapy for deep fungal infection.
Muller RJ
Oncology (Williston Park); 2001 Nov; 15(11 Suppl 9):21-5. PubMed ID: 11757847
[TBL] [Abstract][Full Text] [Related]
32. Amphotericin B: 30 years of clinical experience.
Gallis HA; Drew RH; Pickard WW
Rev Infect Dis; 1990; 12(2):308-29. PubMed ID: 2184499
[TBL] [Abstract][Full Text] [Related]
33. Candiduria as an early marker of disseminated infection in critically ill surgical patients: the role of fluconazole therapy.
Nassoura Z; Ivatury RR; Simon RJ; Jabbour N; Stahl WM
J Trauma; 1993 Aug; 35(2):290-4; discussion 294-5. PubMed ID: 8355311
[TBL] [Abstract][Full Text] [Related]
34. Intradialytic administration of amphotericin B: clinical observations on efficacy and safety.
Wood JE; Mahnensmith MP; Mahnensmith RL; Perazella MA
Am J Med Sci; 2004 Jan; 327(1):5-8. PubMed ID: 14722389
[TBL] [Abstract][Full Text] [Related]
35. Amphotericin-B colloidal dispersion. A review of its use against systemic fungal infections and visceral leishmaniasis.
Brogden RN; Goa KL; Coukell AJ
Drugs; 1998 Sep; 56(3):365-83. PubMed ID: 9777313
[TBL] [Abstract][Full Text] [Related]
36. [A retrospective study of amphotericin B treatment for invasive fungal infection].
Ma XJ; Li GP; Zhou J; Wang A; Li TS
Zhonghua Nei Ke Za Zhi; 2007 Sep; 46(9):718-20. PubMed ID: 18028796
[TBL] [Abstract][Full Text] [Related]
37. Treatment of systemic fungal infections in older patients: achieving optimal outcomes.
Kauffman CA; Hedderwick SA
Drugs Aging; 2001; 18(5):313-23. PubMed ID: 11392440
[TBL] [Abstract][Full Text] [Related]
38. Torulopsis infection extensively involving urinary tract.
Takeuchi H; Tomoyoshi T
Urology; 1983 Aug; 22(2):173-5. PubMed ID: 6683903
[TBL] [Abstract][Full Text] [Related]
39. Antibiotic use in the critical care unit.
Ambrose PG; Owens RC; Quintiliani R; Yeston N; Crowe HM; Cunha BA; Nightingale CH
Crit Care Clin; 1998 Apr; 14(2):283-308. PubMed ID: 9561818
[TBL] [Abstract][Full Text] [Related]
40. An epidemic of invasive fungal infection in a stem cell transplant unit; response to high-dose liposomal amphotericin B.
Ryan C; McNicholsan S; O'Connell B; Forde S; Keoghan M; McCann SR
Hematol J; 2004; 5(6):548-51. PubMed ID: 15570304
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
